Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
Receptor-targeted radionuclide therapy (RTRT) combines the power of particle-emitting radionuclides with the receptor-targeting capabilities of biomolecules, including antibodies and peptides. There are numerous radionuclides, but only a handful possess the necessary characteristics for targeted alp...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mazandaran University of Medical Sciences
2025-01-01
|
| Edice: | Journal of Mazandaran University of Medical Sciences |
| Témata: | |
| On-line přístup: | http://jmums.mazums.ac.ir/article-1-21231-en.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
